I do find the impact of ivermectin on people's basic critical thinking quite fascinating. This article is filled with obvious, easily checkable lies, but just look at the popularity
The primary claim is that an ivermectin researcher, Andrew Hill, received a grant for $40mil in exchange for lying about ivermectin
This claim centers around a grant awarded by UNITAID to the University of Liverpool for $32mil (the article incorrectly states $40mil) - UNITAID released a press release on the 12th of Jan, the preprint was published on the 8th. Dodgy, right?
Except, as even a very quick Google shows, the grant was ACTUALLY AWARDED in...2019
So in fact, the grant was awarded long before anyone looked at ivermectin for COVID-19. The UNITAID press release in 2021 was actually about the *launch* of the centre, not the award of funds
This statement, the key argument of the article, is a straightforward untruth. A lie. The grant was awarded long before this, it was for a different amount, and even the press release went up four days AFTER the preprint
The entire article is based on a lie that takes minutes to disprove. That press release is the second result on Google. And yet, it's printed and spreads because no one in the ivermectin crowd appears to care if it is true or not 🤷♂️
(I didn't even discuss the fact that the grant is primarily for early stage research, in a different department of the university to Hill, and as far as I can tell has nothing whatsoever to do with him. But even the temporal correlation is a lie)
For transparency, I've talked to Andrew Hill three times on zoom about ivermectin and he included me on a poster his team recently presented about the impacts of fraud on the literature
• • •
Missing some Tweet in this thread? You can try to
force a refresh
The final large published trial on ivermectin for COVID-19, PRINCIPLE, is now out. Main findings:
1. Clinically unimportant (~1-2day reduction) in time to resolution of symptoms. 2. No benefit for hospitalization/death.
Now, you may be asking "why does anyone care at all any more about ivermectin for COVID?" to which I would respond "yes"
We already knew pretty much everything this study shows. That being said, always good to have more data!
The study is here:
For me, the main finding is pretty simple - ivermectin didn't impact the likelihood of people going to hospital or dying from COVID-19. This has now been shown in every high-quality study out there.pubmed.ncbi.nlm.nih.gov/38431155/
What's particularly interesting is a finding that the authors don't really discuss in their conclusion. These results appear to show that gender affirming care is associated with a reduction in suicide risk 1/n
2/n The paper is a retrospective cohort study that compares young adults and some teens who were referred for gender related services in Finland with a cohort that was matched using age and sex. The median age in the study was 19, so the majority of the population are adults.
3/n The study is very limited. The authors had access to the Finnish registries which include a wide range of data, but chose to only correct their cohorts for age, sex, and number of psychiatric appointments prior to their inclusion in the cohort.
These headlines have to be some of the most ridiculous I've seen in a while
The study tested 18 different PFAS in a tiny sample of 176 people. Of those, one had a barely significant association with thyroid cancer
This is genuinely just not news at all
Here's the study. I'm somewhat surprised it even got published if I'm honest. A tiny case-control study, they looked at 88 people with thyroid cancer and 88 controls thelancet.com/journals/ebiom…
Here are the main results. There was a single measured PFAS which had a 'significant' association with the cancer, the others just look a bit like noise to me
A new study has gone viral for purportedly showing that running therapy had similar efficacy to medication for depression
Which is weird, because a) it's not a very good study and b) seems not to show that at all 1/n
2/n The study is here. The authors describe it as a "partially randomized patient preference design", which is a wildly misleading term. In practice, this is simply a cohort study, where ~90% of the patients self-selected into their preferred treatment sciencedirect.com/science/articl…
3/n This is a big problem, because it means that there are likely confounding factors between the two groups (i.e. who is likely to choose running therapy over meds?). Instead of a useful, randomized trial, this is a very small (n=141) non-randomized paper
The study showed that COVID-19 had, if anything, very few long-term issues for children! As a new father, I find this data very reassuring regarding #LongCovid in kids 1/n
2/n The study is here, it's a retrospective cohort comparing children aged 0-14 who had COVID-19 to a matched control using a database of primary care visits in Italy onlinelibrary.wiley.com/doi/10.1111/ap…
3/ The authors found that there was an increased risk of a range of diagnoses for the kids with COVID-19 after their acute disease, including things like runny noses, anxiety/depression, diarrhoea, etc
This study has recently gone viral, with people saying that it shows that nearly 20% of highly vaccinated people get Long COVID
I don't think it's reasonable to draw these conclusions based on this research. Let's talk about bias 1/n
2/n The study is here. It is a survey of people who tested positive to COVID-19 in Western Australia from July-Aug 2022 medrxiv.org/content/10.110…
3/n This immediately gives us our first source of bias
We KNOW that most cases of COVID-19 were missed at this point in the pandemic, so we're only getting the sample of those people who were sick enough to go and get tested